< Back to scientific publications

Magazine 4.3

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.

Authors: Pellicelli A et al

Date: May 20

Scope of interest: infectious/hepatological




You may also be interested in:

Magazine 9.54

Epileptic seizures heralding a relapse in high grade gliomas.

Authors: Di Bonaventura C, Albini M, D'Elia A, Fattouch J,Fanella M, Morano A, Lucignani G, Manfredi M, Colonnese C, Salvati M, Vanacore N, Berardelli A, Giallonardo AT.

Date: 2017

Scope of interest: Epilepsy


Read details
Magazine 8.33

Structural Cerebellar Abnormalities and Parkinsonism in Patients with 22q11.2 Deletion Syndrome

Authors: Piervincenzi C, Fanella M, Petsas N, Frascarelli M, Morano A, Accinni T, Di Fabio F, Di Bonaventura C, Berardelli A, Pantano P.

Date: 2022

Scope of interest: Neuroimaging/rare diseases


Read details
Magazine 14.17

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First ItalianζoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2021

Scope of interest: Epilepsy


Read details